Spectral AI, Inc. (NASDAQ: MDAIW) Stock Competitors & Peer Comparison
See MDAIW's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Specialties Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for MDAIW and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| MDAIW | $0.47 | +1.85% | 15.1M | -1.34 | -$0.35 | N/A |
| ALC | $64.75 | -1.05% | 31.6B | 20.36 | $3.18 | +0.55% |
| STE | $210.01 | -0.30% | 20.5B | 20.17 | $10.42 | +1.22% |
| MLAB | $129.94 | -0.79% | 727.1M | 13.11 | $9.91 | +0.49% |
| QDEL | $10.54 | -0.52% | 718.7M | 7.87 | $1.34 | N/A |
| BWAY | $13.20 | -2.08% | 517.7M | 33.53 | $0.39 | N/A |
| MASS | $12.34 | +4.14% | 506.3M | -20.57 | -$0.60 | N/A |
| SI | $18.90 | +0.59% | 392M | -10.92 | -$1.73 | N/A |
| MOBI | $9.45 | +4.77% | 314.2M | -4.90 | -$1.93 | N/A |
| LAB | $0.74 | +3.83% | 289.9M | -10.58 | -$0.07 | N/A |
Stock Comparison
Alcon Inc. (NYSE: ALC)
MDAIW vs ALC Comparison October 2026
Spectral AI, Inc. (NASDAQ: MDAIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDAIW stands at 15.1M. In comparison, ALC has a market cap of 31.6B. Regarding current trading prices, MDAIW is priced at $0.47 on the NASDAQ, while ALC trades at $64.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDAIW currently has a P/E ratio of -1.34, whereas ALC's P/E ratio is 20.36. In terms of profitability, MDAIW's ROE is N/A, compared to ALC's ROE of +0.03%. Regarding short-term risk, MDAIW is less volatile compared to ALC. This indicates lower risk in terms of short-term price fluctuations for MDAIW.Check ALC's competition here
STERIS plc (NYSE: STE)
MDAIW vs STE Comparison October 2026
Spectral AI, Inc. (NASDAQ: MDAIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDAIW stands at 15.1M. In comparison, STE has a market cap of 20.5B. Regarding current trading prices, MDAIW is priced at $0.47 on the NASDAQ, while STE trades at $210.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDAIW currently has a P/E ratio of -1.34, whereas STE's P/E ratio is 20.17. In terms of profitability, MDAIW's ROE is N/A, compared to STE's ROE of +0.11%. Regarding short-term risk, MDAIW is less volatile compared to STE. This indicates lower risk in terms of short-term price fluctuations for MDAIW.Check STE's competition here
Mesa Laboratories, Inc. (NASDAQ: MLAB)
MDAIW vs MLAB Comparison October 2026
Spectral AI, Inc. (NASDAQ: MDAIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDAIW stands at 15.1M. In comparison, MLAB has a market cap of 727.1M. Regarding current trading prices, MDAIW is priced at $0.47 on the NASDAQ, while MLAB trades at $129.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDAIW currently has a P/E ratio of -1.34, whereas MLAB's P/E ratio is 13.11. In terms of profitability, MDAIW's ROE is N/A, compared to MLAB's ROE of +0.03%. Regarding short-term risk, MDAIW is less volatile compared to MLAB. This indicates lower risk in terms of short-term price fluctuations for MDAIW.Check MLAB's competition here
QuidelOrtho Corporation (NASDAQ: QDEL)
MDAIW vs QDEL Comparison October 2026
Spectral AI, Inc. (NASDAQ: MDAIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDAIW stands at 15.1M. In comparison, QDEL has a market cap of 718.7M. Regarding current trading prices, MDAIW is priced at $0.47 on the NASDAQ, while QDEL trades at $10.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDAIW currently has a P/E ratio of -1.34, whereas QDEL's P/E ratio is 7.87. In terms of profitability, MDAIW's ROE is N/A, compared to QDEL's ROE of -0.55%. Regarding short-term risk, MDAIW is less volatile compared to QDEL. This indicates lower risk in terms of short-term price fluctuations for MDAIW.Check QDEL's competition here
BrainsWay Ltd. (NASDAQ: BWAY)
MDAIW vs BWAY Comparison October 2026
Spectral AI, Inc. (NASDAQ: MDAIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDAIW stands at 15.1M. In comparison, BWAY has a market cap of 517.7M. Regarding current trading prices, MDAIW is priced at $0.47 on the NASDAQ, while BWAY trades at $13.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDAIW currently has a P/E ratio of -1.34, whereas BWAY's P/E ratio is 33.53. In terms of profitability, MDAIW's ROE is N/A, compared to BWAY's ROE of +0.13%. Regarding short-term risk, MDAIW is less volatile compared to BWAY. This indicates lower risk in terms of short-term price fluctuations for MDAIW.Check BWAY's competition here
908 Devices Inc. (NASDAQ: MASS)
MDAIW vs MASS Comparison October 2026
Spectral AI, Inc. (NASDAQ: MDAIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDAIW stands at 15.1M. In comparison, MASS has a market cap of 506.3M. Regarding current trading prices, MDAIW is priced at $0.47 on the NASDAQ, while MASS trades at $12.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDAIW currently has a P/E ratio of -1.34, whereas MASS's P/E ratio is -20.57. In terms of profitability, MDAIW's ROE is N/A, compared to MASS's ROE of -0.25%. Regarding short-term risk, MDAIW is less volatile compared to MASS. This indicates lower risk in terms of short-term price fluctuations for MDAIW.Check MASS's competition here
Shoulder Innovations, Inc. (NYSE: SI)
MDAIW vs SI Comparison October 2026
Spectral AI, Inc. (NASDAQ: MDAIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDAIW stands at 15.1M. In comparison, SI has a market cap of 392M. Regarding current trading prices, MDAIW is priced at $0.47 on the NASDAQ, while SI trades at $18.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDAIW currently has a P/E ratio of -1.34, whereas SI's P/E ratio is -10.92. In terms of profitability, MDAIW's ROE is N/A, compared to SI's ROE of -0.26%. Regarding short-term risk, MDAIW is less volatile compared to SI. This indicates lower risk in terms of short-term price fluctuations for MDAIW.Check SI's competition here
Mobia Medical, Inc. Common Stock (NASDAQ: MOBI)
MDAIW vs MOBI Comparison October 2026
Spectral AI, Inc. (NASDAQ: MDAIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDAIW stands at 15.1M. In comparison, MOBI has a market cap of 314.2M. Regarding current trading prices, MDAIW is priced at $0.47 on the NASDAQ, while MOBI trades at $9.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDAIW currently has a P/E ratio of -1.34, whereas MOBI's P/E ratio is -4.90. In terms of profitability, MDAIW's ROE is N/A, compared to MOBI's ROE of +0.80%. Regarding short-term risk, MDAIW is less volatile compared to MOBI. This indicates lower risk in terms of short-term price fluctuations for MDAIW.Check MOBI's competition here
Standard BioTools Inc. (NASDAQ: LAB)
MDAIW vs LAB Comparison October 2026
Spectral AI, Inc. (NASDAQ: MDAIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDAIW stands at 15.1M. In comparison, LAB has a market cap of 289.9M. Regarding current trading prices, MDAIW is priced at $0.47 on the NASDAQ, while LAB trades at $0.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDAIW currently has a P/E ratio of -1.34, whereas LAB's P/E ratio is -10.58. In terms of profitability, MDAIW's ROE is N/A, compared to LAB's ROE of -0.18%. Regarding short-term risk, MDAIW is less volatile compared to LAB. This indicates lower risk in terms of short-term price fluctuations for MDAIW.Check LAB's competition here
Anika Therapeutics, Inc. (NASDAQ: ANIK)
MDAIW vs ANIK Comparison October 2026
Spectral AI, Inc. (NASDAQ: MDAIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDAIW stands at 15.1M. In comparison, ANIK has a market cap of 263.1M. Regarding current trading prices, MDAIW is priced at $0.47 on the NASDAQ, while ANIK trades at $19.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDAIW currently has a P/E ratio of -1.34, whereas ANIK's P/E ratio is 40.12. In terms of profitability, MDAIW's ROE is N/A, compared to ANIK's ROE of -0.03%. Regarding short-term risk, MDAIW is less volatile compared to ANIK. This indicates lower risk in terms of short-term price fluctuations for MDAIW.Check ANIK's competition here
Edap Tms S.a. (NASDAQ: EDAP)
MDAIW vs EDAP Comparison October 2026
Spectral AI, Inc. (NASDAQ: MDAIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDAIW stands at 15.1M. In comparison, EDAP has a market cap of 178.2M. Regarding current trading prices, MDAIW is priced at $0.47 on the NASDAQ, while EDAP trades at $4.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDAIW currently has a P/E ratio of -1.34, whereas EDAP's P/E ratio is -5.80. In terms of profitability, MDAIW's ROE is N/A, compared to EDAP's ROE of -3.13%. Regarding short-term risk, MDAIW is less volatile compared to EDAP. This indicates lower risk in terms of short-term price fluctuations for MDAIW.Check EDAP's competition here
Nyxoah S.A. (NASDAQ: NYXH)
MDAIW vs NYXH Comparison October 2026
Spectral AI, Inc. (NASDAQ: MDAIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDAIW stands at 15.1M. In comparison, NYXH has a market cap of 138.1M. Regarding current trading prices, MDAIW is priced at $0.47 on the NASDAQ, while NYXH trades at $1.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDAIW currently has a P/E ratio of -1.34, whereas NYXH's P/E ratio is -0.55. In terms of profitability, MDAIW's ROE is N/A, compared to NYXH's ROE of -1.80%. Regarding short-term risk, MDAIW is less volatile compared to NYXH. This indicates lower risk in terms of short-term price fluctuations for MDAIW.Check NYXH's competition here
Trinity Biotech plc (NASDAQ: TRIB)
MDAIW vs TRIB Comparison October 2026
Spectral AI, Inc. (NASDAQ: MDAIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDAIW stands at 15.1M. In comparison, TRIB has a market cap of 130.2M. Regarding current trading prices, MDAIW is priced at $0.47 on the NASDAQ, while TRIB trades at $6.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDAIW currently has a P/E ratio of -1.34, whereas TRIB's P/E ratio is -0.11. In terms of profitability, MDAIW's ROE is N/A, compared to TRIB's ROE of +0.68%. Regarding short-term risk, MDAIW is less volatile compared to TRIB. This indicates lower risk in terms of short-term price fluctuations for MDAIW.Check TRIB's competition here
Apyx Medical Corporation (NASDAQ: APYX)
MDAIW vs APYX Comparison October 2026
Spectral AI, Inc. (NASDAQ: MDAIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDAIW stands at 15.1M. In comparison, APYX has a market cap of 105.5M. Regarding current trading prices, MDAIW is priced at $0.47 on the NASDAQ, while APYX trades at $2.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDAIW currently has a P/E ratio of -1.34, whereas APYX's P/E ratio is -12.52. In terms of profitability, MDAIW's ROE is N/A, compared to APYX's ROE of -0.79%. Regarding short-term risk, MDAIW is less volatile compared to APYX. This indicates lower risk in terms of short-term price fluctuations for MDAIW.Check APYX's competition here
SkinHealth Systems Inc. (NASDAQ: SKIN)
MDAIW vs SKIN Comparison October 2026
Spectral AI, Inc. (NASDAQ: MDAIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDAIW stands at 15.1M. In comparison, SKIN has a market cap of 81.6M. Regarding current trading prices, MDAIW is priced at $0.47 on the NASDAQ, while SKIN trades at $0.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDAIW currently has a P/E ratio of -1.34, whereas SKIN's P/E ratio is -2.86. In terms of profitability, MDAIW's ROE is N/A, compared to SKIN's ROE of -0.48%. Regarding short-term risk, MDAIW is less volatile compared to SKIN. This indicates lower risk in terms of short-term price fluctuations for MDAIW.Check SKIN's competition here
Spectral AI, Inc. (NASDAQ: MDAI)
MDAIW vs MDAI Comparison October 2026
Spectral AI, Inc. (NASDAQ: MDAIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDAIW stands at 15.1M. In comparison, MDAI has a market cap of 52.8M. Regarding current trading prices, MDAIW is priced at $0.47 on the NASDAQ, while MDAI trades at $1.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDAIW currently has a P/E ratio of -1.34, whereas MDAI's P/E ratio is -3.69. In terms of profitability, MDAIW's ROE is N/A, compared to MDAI's ROE of +1.21%. Regarding short-term risk, MDAIW is less volatile compared to MDAI. This indicates lower risk in terms of short-term price fluctuations for MDAIW.Check MDAI's competition here
DarioHealth Corp. (NASDAQ: DRIO)
MDAIW vs DRIO Comparison October 2026
Spectral AI, Inc. (NASDAQ: MDAIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDAIW stands at 15.1M. In comparison, DRIO has a market cap of 51.5M. Regarding current trading prices, MDAIW is priced at $0.47 on the NASDAQ, while DRIO trades at $6.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDAIW currently has a P/E ratio of -1.34, whereas DRIO's P/E ratio is -1.20. In terms of profitability, MDAIW's ROE is N/A, compared to DRIO's ROE of +1.04%. Regarding short-term risk, MDAIW is less volatile compared to DRIO. This indicates lower risk in terms of short-term price fluctuations for MDAIW.Check DRIO's competition here
HeartBeam, Inc. (NASDAQ: BEAT)
MDAIW vs BEAT Comparison October 2026
Spectral AI, Inc. (NASDAQ: MDAIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDAIW stands at 15.1M. In comparison, BEAT has a market cap of 20.3M. Regarding current trading prices, MDAIW is priced at $0.47 on the NASDAQ, while BEAT trades at $0.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDAIW currently has a P/E ratio of -1.34, whereas BEAT's P/E ratio is -0.72. In terms of profitability, MDAIW's ROE is N/A, compared to BEAT's ROE of -6.87%. Regarding short-term risk, MDAIW is less volatile compared to BEAT. This indicates lower risk in terms of short-term price fluctuations for MDAIW.Check BEAT's competition here
HeartBeam, Inc. (NASDAQ: BEATW)
MDAIW vs BEATW Comparison October 2026
Spectral AI, Inc. (NASDAQ: MDAIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDAIW stands at 15.1M. In comparison, BEATW has a market cap of 4.3M. Regarding current trading prices, MDAIW is priced at $0.47 on the NASDAQ, while BEATW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDAIW currently has a P/E ratio of -1.34, whereas BEATW's P/E ratio is -0.01. In terms of profitability, MDAIW's ROE is N/A, compared to BEATW's ROE of -6.87%. Regarding short-term risk, MDAIW is less volatile compared to BEATW. This indicates lower risk in terms of short-term price fluctuations for MDAIW.Check BEATW's competition here
WORK Medical Technology Group Ltd. Class A (NASDAQ: WOK)
MDAIW vs WOK Comparison October 2026
Spectral AI, Inc. (NASDAQ: MDAIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDAIW stands at 15.1M. In comparison, WOK has a market cap of 4.3M. Regarding current trading prices, MDAIW is priced at $0.47 on the NASDAQ, while WOK trades at $1.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDAIW currently has a P/E ratio of -1.34, whereas WOK's P/E ratio is N/A. In terms of profitability, MDAIW's ROE is N/A, compared to WOK's ROE of -0.19%. Regarding short-term risk, MDAIW is less volatile compared to WOK. This indicates lower risk in terms of short-term price fluctuations for MDAIW.Check WOK's competition here
QTREX Quantum Ltd. Warrant (NASDAQ: QTEXW)
MDAIW vs QTEXW Comparison October 2026
Spectral AI, Inc. (NASDAQ: MDAIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDAIW stands at 15.1M. In comparison, QTEXW has a market cap of 3.5M. Regarding current trading prices, MDAIW is priced at $0.47 on the NASDAQ, while QTEXW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDAIW currently has a P/E ratio of -1.34, whereas QTEXW's P/E ratio is -0.01. In terms of profitability, MDAIW's ROE is N/A, compared to QTEXW's ROE of N/A. Regarding short-term risk, MDAIW is less volatile compared to QTEXW. This indicates lower risk in terms of short-term price fluctuations for MDAIW.Check QTEXW's competition here
iTonic Holdings Ltd. (NASDAQ: ITOC)
MDAIW vs ITOC Comparison October 2026
Spectral AI, Inc. (NASDAQ: MDAIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDAIW stands at 15.1M. In comparison, ITOC has a market cap of 2.6M. Regarding current trading prices, MDAIW is priced at $0.47 on the NASDAQ, while ITOC trades at $0.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDAIW currently has a P/E ratio of -1.34, whereas ITOC's P/E ratio is -0.90. In terms of profitability, MDAIW's ROE is N/A, compared to ITOC's ROE of -0.94%. Regarding short-term risk, MDAIW is less volatile compared to ITOC. This indicates lower risk in terms of short-term price fluctuations for MDAIW.Check ITOC's competition here
ENvue Medical, Inc. (NASDAQ: FEED)
MDAIW vs FEED Comparison October 2026
Spectral AI, Inc. (NASDAQ: MDAIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDAIW stands at 15.1M. In comparison, FEED has a market cap of 798K. Regarding current trading prices, MDAIW is priced at $0.47 on the NASDAQ, while FEED trades at $1.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDAIW currently has a P/E ratio of -1.34, whereas FEED's P/E ratio is -0.15. In terms of profitability, MDAIW's ROE is N/A, compared to FEED's ROE of -0.60%. Regarding short-term risk, MDAIW is less volatile compared to FEED. This indicates lower risk in terms of short-term price fluctuations for MDAIW.Check FEED's competition here
Tivic Health Systems, Inc. (NASDAQ: TIVC)
MDAIW vs TIVC Comparison October 2026
Spectral AI, Inc. (NASDAQ: MDAIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDAIW stands at 15.1M. In comparison, TIVC has a market cap of 279.2K. Regarding current trading prices, MDAIW is priced at $0.47 on the NASDAQ, while TIVC trades at $0.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDAIW currently has a P/E ratio of -1.34, whereas TIVC's P/E ratio is -0.04. In terms of profitability, MDAIW's ROE is N/A, compared to TIVC's ROE of -1.65%. Regarding short-term risk, MDAIW is less volatile compared to TIVC. This indicates lower risk in terms of short-term price fluctuations for MDAIW.Check TIVC's competition here